SHREE GANESH REMEDIES LTD

2026-08-21 NSE BSE Web Result 12 Aug

Price

507.6

+1.3%
O:500
H:513
L:490
C:507.6

52W Range

381.1759
+33%/-33%

Market Cap

₹651.50 Cr

Traded: ₹0.32 Cr (0.05%) 0.0x

Free Float: ₹168.93 Cr (0.19% of FF traded)

Volume · 60D trend

6.24 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:-20% 3M:-28% 6M:-5% 12M:+13%

Valuation

P/E42.2
P/B4.0
P/S6.6
EV/EBIT20.0

Business Strength

ROE17.3%
ROCE19.5%
OPM35.8%
NPM21.1%

Growth (3Y CAGR)

EPS-18.2%
Sales--
Profit--
3Y Return+26.0%

Balance Sheet

Debt/Equity0.2
Debt37.36 Cr
Pledge0.0%
CWIP/Fixed Asset8.6%

Cash Position

CFO/NP134.8%
FCF7.48 Cr
FCF 3Y Avg--
Cash/MCap2.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle238 days
Tradeable Free Float25.9%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
--
--
--
--
--
Sales
--
+11.0%
--
--
-17.0%
Decelerating
Profit
--
+17.0%
--
--
-38.0%
Decelerating
Return
--
+20.0%
+26.0%
-32.0%
--
Stable

Quarterly Results

Jun 2026

12 Aug
Rev
14 Cr
----
OPM23.3%
NPM--
PAT
-68% YoY1 Cr
EPS
--0.9

Mar 2026

14 May
Rev
33 Cr
+36% YoY+57% QoQ
OPM34.3%
NPM18.9%
PAT
-5% YoY6 Cr
EPS
-5% YoY4.9

Dec 2025

23 Jan
Rev
21 Cr
-22% YoY-30% QoQ
OPM31.9%
NPM14.6%
PAT
-43% YoY3 Cr
EPS
-43% YoY2.4

Sep 2025

PDF
Rev
30 Cr
-6% YoY+23% QoQ
OPM31.7%
NPM16.4%
PAT
-23% YoY5 Cr
EPS
-23% YoY3.9

Jun 2025

PDF
Rev
25 Cr
-0% YoY+1% QoQ
OPM29.6%
NPM14.0%
PAT
-26% YoY3 Cr
EPS
-26% YoY2.7

Mar 2025

PDF
Rev
24 Cr
-35% YoY-10% QoQ
OPM40.4%
NPM27.0%
PAT
-48% YoY7 Cr
EPS
-48% YoY5.1

Dec 2024

PDF
Rev
27 Cr
---16% QoQ
OPM36.6%
NPM20.0%
PAT
--5 Cr
EPS
--4.2

Sep 2024

PDF
Rev
32 Cr
--+30% QoQ
OPM35.0%
NPM19.8%
PAT
--6 Cr
EPS
--5.0

Jun 2024

PDF
Rev
25 Cr
---34% QoQ
OPM32.8%
NPM18.8%
PAT
--5 Cr
EPS
--3.6

Mar 2024

PDF
Rev
37 Cr
--+77% QoQ
OPM45.4%
NPM33.7%
PAT
--13 Cr
EPS
--9.8

Dec 2021

PDF
Rev
21 Cr
+59% YoY+25% QoQ
OPM27.3%
NPM19.9%
PAT
+52% YoY4 Cr
EPS
+52% YoY3.3

Sep 2021

PDF
Rev
17 Cr
+47% YoY+34% QoQ
OPM26.2%
NPM17.8%
PAT
-2% YoY3 Cr
EPS
-2% YoY2.4

Jun 2021

PDF
Rev
13 Cr
---5% QoQ
OPM24.1%
NPM18.5%
PAT
--2 Cr
EPS
--1.8

Dec 2020

Rev
13 Cr
--+15% QoQ
OPM24.0%
NPM20.9%
PAT
--3 Cr
EPS
--2.2

Sep 2020

Rev
12 Cr
----
OPM36.5%
NPM26.8%
PAT
--3 Cr
EPS
--2.4

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.25
Interest Coverage93.0x
Promoter Pledge0.0%
Borrowings38 Cr

Efficiency

Receivable Days75 days
Inventory Days223 days
Payable Days61 days
Cash Conversion cycle238 days

Cash Position

Operating Cash Flow31 Cr
Investing Cash Flow-35 Cr
Financing Cash Flow-1 Cr
Free Cash Flow7 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2021PDF ↗
Sep 2021PDF ↗
Jun 2021PDF ↗
Dec 2020
Sep 2020
Sales143321302524273225372117131312
Expenses11221421171517211720151310107
Operating Profit311710710101181764334
OPM %23.3%34.3%31.9%31.7%29.6%40.4%36.6%35.0%32.8%45.4%27.3%26.2%24.1%24.0%36.5%
Other Income111112101110110
Interest011111000000000
Depreciation233322322211101
Profit Before Tax2947598961664334
Tax %27.4%28.2%22.4%26.2%25.0%24.8%27.9%25.8%26.7%22.5%25.4%22.8%28.8%20.4%22.9%
Net Profit1635375651343233
Exceptional Items------------------------------
EPS (Rs)0.94.92.43.92.75.14.25.03.69.83.32.41.82.22.4
Sales Growth (YoY)--35.9%-22.0%-6.2%-0.4%-34.6%--------59.4%47.3%------
Sales Growth (QoQ)--57.3%-30.4%22.9%1.0%-9.7%-16.3%30.5%-33.6%76.7%24.5%34.4%-4.8%15.1%--
OP Growth (YoY)-54.1%15.2%-32.1%-14.9%-10.2%-41.7%--------81.4%5.7%------
OP Growth (QoQ)-70.6%69.1%-30.0%31.8%-26.1%-0.3%-12.4%39.1%-52.0%--29.7%45.9%---24.5%--
Profit Growth (YoY)-68.0%-5.0%-43.0%-23.0%-26.0%-48.0%--------52.0%-2.0%------
EPS Growth (YoY)---4.9%-42.9%-22.6%-25.7%-47.9%--------51.9%-2.1%------
EPS Growth (QoQ)--102.5%-37.6%43.5%-47.6%21.6%-15.4%37.9%-63.2%200.0%39.0%29.0%-15.3%-10.4%--
OP Margin--34.3%31.9%31.7%29.6%40.4%36.6%35.0%32.8%45.4%27.3%26.2%24.1%24.0%36.5%
Net Margin--18.9%14.6%16.4%14.0%27.0%20.0%19.8%18.8%33.7%19.9%17.8%18.5%20.9%26.8%
Material Cost %--42.8%30.0%41.5%35.4%23.9%31.1%41.0%33.9%35.0%51.2%52.6%48.9%47.9%34.0%
Employee Cost %--8.6%13.6%9.8%10.9%11.0%9.8%7.5%9.5%7.5%5.7%6.3%8.0%7.8%8.5%
P/S6.587.176.36------------------------
P/E42.2344.0835.37------------------------
P/B4.004.804.15------------------------

Shareholding Pattern

Shareholders:8.4K (+25.1%)
Current MixDec 2025

Exchange Filings

50
Company Update21 Aug 2026

Newspaper Publication for Notice of Annual General Meeting

Others20 Aug 2026

Annual Report FY 2025-26

Company Update13 Aug 2026

Newspaper Publication

Company Update13 Aug 2026

Investor Presentation

Company Update13 Aug 2026

Press Release

Company Update12 Aug 2026

Appointment of Cost Auditors

Result12 Aug 2026

Financial Results for the quarter ended on June 30, 2026

Board Meeting12 Aug 2026

Outcome of Board Meeting

Board Meeting08 Aug 2026

Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited (Standalone ....

Company Update17 Jul 2026

Appointment of Additional Director (Non executive, Independent)

Company Update13 Jul 2026

Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

Company Update29 Jun 2026

Clarification

Insider Trading / SAST25 Jun 2026

Intimation of Closure of Trading Window

Company Update25 Jun 2026

Intimation of Schedule of Analyst /Institutional Investor Meetings

Company Update25 Jun 2026

The Exchange has sought clarification from Shree Ganesh Remedies Ltd on June 25, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

BSE
Company Update25 May 2026

Annual Secretarial Compliance Report for the year ended March 31, 2026

Company Update20 May 2026

Transcript of Earnings Call

Company Update16 May 2026

Audio Recording - Earnings Call held on May 15, 2026

Company Update15 May 2026

Newspaper Publication

Company Update15 May 2026

Press Release

Company Update14 May 2026

Investor Presentation

Result14 May 2026

Financial Results

Board Meeting14 May 2026

Outcome of Board Meeting

Company Update12 May 2026

Intimation for invitation of Earnings Conference Call.

Board Meeting11 May 2026

Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve the Audited Standalone ....

Company Update08 Apr 2026

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

AGM/EGM06 Apr 2026

Voting Results

AGM/EGM06 Apr 2026

Proceedings of Extra-Ordinary General Meeting

Insider Trading / SAST21 Mar 2026

Intimation of Closure of Trading Window

Company Update14 Mar 2026

Newspaper Publication

AGM/EGM13 Mar 2026

Notice of Extraordinary General Meeting

Company Update24 Jan 2026

Newspaper publication for Financial Results

Board Meeting23 Jan 2026

Outcome of Board Meeting

Company Update23 Jan 2026

Investor Presentation

Company Update23 Jan 2026

Press Release

Result23 Jan 2026

Financial Results for quarter and nine months ended December 31, 2025

Company Update16 Jan 2026

Re-appointment of Mr. Parth Chandulal Kothia as Whole-time Director of the Company

Board Meeting16 Jan 2026

Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Others16 Jan 2026

Outcome of Board Meeting

Company Update06 Jan 2026

Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018

Insider Trading / SAST26 Dec 2025

Closure of Trading Window

Company Update16 Nov 2025

Transcript of Earnings Conference Call

Company Update12 Nov 2025

Audio Recording - Earnings Call held on November 12, 2025

Company Update08 Nov 2025

Newspaper Publication

Result07 Nov 2025

Financial Results for quarter and half year ended September 30, 2025

Company Update07 Nov 2025

Press Release

Company Update07 Nov 2025

Investor Presentation

Company Update07 Nov 2025

Resignation of Independent Director

Board Meeting07 Nov 2025

Outcome of Board Meeting

Company Update07 Nov 2025

Intimation for invitation of Earnings Conference Call.

Annual Reports

9

2025

2024

2023

2022

2021

2020

2019

2018

2017

Concalls

9

Jan 2026

31 Jan 2026

Nov 2025

30 Nov 2025

Aug 2025

31 Aug 2025

May 2025

31 May 2025

Feb 2025

28 Feb 2025

Nov 2024

30 Nov 2024

Aug 2024

31 Aug 2024

May 2023

31 May 2023

Mar 2021

31 Mar 2021

Held by ETFs

1 ETFs hold SGRL · sorted by weight

#ETFWeight %
1

MOHEALTH

MOTILALAMC - MOHEALTH

0.01%

Held by Mutual Funds

1 schemes hold SGRL · sorted by weight

#SchemeWeight %
1

Bandhan BSE Healthcare Index Fund

Bandhan Mutual Fund

0.01%